Here’s Why You Should Retain Allscripts (MDRX) Stock For Now

Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2021 performance, along with various innovation milestones, is expected to contribute further. However, healthcare regulatory changes and foreign exchange concerns persist.

Over the past year, this Zacks Rank #3 (Hold) stock has surged 35.3% against 29.2% fall of the industry it belongs to. The S&P 500 composite rose 31.7% in the said time frame.

The renowned IT solutions and services provider has a market capitalization of $1.78 billion. The company projects 9.7% growth for the next five years and expects to maintain its strong performance. It has delivered an earnings surprise of 24.35% for the past four quarters, on average.

Read More